Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Albireo Pharma Inc (NQ: ALBO ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Mar 2, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Albireo Pharma Inc < Previous 1 2 3 4 Next > Analyst Ratings for Albireo Pharma February 15, 2023 Via Benzinga ALBIREO PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Albireo Pharma, Inc. - ALBO January 24, 2023 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT) January 20, 2023 From Brodsky & Smith LLC Via GlobeNewswire Cowen & Co. Downgrades Albireo Pharma: Here's What You Need To Know January 11, 2023 Via Benzinga Expert Ratings for Albireo Pharma January 11, 2023 Via Benzinga Looking Into Albireo Pharma's Return On Capital Employed December 05, 2022 Via Benzinga What 5 Analyst Ratings Have To Say About Albireo Pharma October 12, 2022 Analysts have provided the following ratings for Albireo Pharma (NASDAQ:ALBO) within the last quarter: Via Benzinga Why These Two Biotech Stocks Blasted Higher This Week January 13, 2023 There's nothing like a big-premium buyout to send a company's share price to the moon. Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For January 11, 2023 January 11, 2023 Via Benzinga ALBIREO PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Albireo Pharma, Inc. - ALBO January 10, 2023 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT) January 10, 2023 From Brodsky & Smith LLC Via GlobeNewswire S&P 500 Gains 0.6%; Albireo Pharma Shares Spike Higher January 09, 2023 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Monday. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023 January 10, 2023 Via Benzinga Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 09, 2023 Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session January 09, 2023 Via Benzinga Nasdaq Surges Over 200 Points; Crude Oil Rises 2% January 09, 2023 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Monday. Via Benzinga 2 Tiny Nasdaq Stocks Making Major Merger Moves Monday January 09, 2023 The market is moving higher, and these small companies are helping. Via The Motley Fool Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday January 09, 2023 U.S. stocks traded higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session. Via Benzinga US Stocks Open Higher; Dow Rises 150 Points January 09, 2023 U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Monday. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 9, 2023 January 09, 2023 Via Benzinga ALBO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Albireo Pharma, Inc. Is Fair to Shareholders January 09, 2023 From Halper Sadeh LLC Via Business Wire 12 Health Care Stocks Moving In Monday's Pre-Market Session January 09, 2023 Via Benzinga Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket January 09, 2023 Gainers CinCor Pharma, Inc. (NASDAQ: CINC) rose 140.2% to $28.30 in pre-market trading after AstraZeneca announced plans to buy the company for up to $1.8 billion. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday January 09, 2023 We're starting off the week with a look at the biggest pre-market stock movers traders need to know about on Monday morning! Via InvestorPlace France-Based Ipsen Acquires Albireo Pharma Enriching Its Rare Disease Portfolio, Pipeline January 09, 2023 Via Benzinga Have A Look At William Blair's Top Biotech Picks For 2023 December 25, 2022 William Blair & Company's report outlined some key themes and significant trends to monitor while entering 2023, providing its top stock ideas for the upcoming 12-month period. Via Benzinga Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session November 09, 2022 Gainers Via Benzinga Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday November 10, 2022 Gainers Via Benzinga Analysts Expect Mirum Pharma's Liver Disease Candidate Might Exceed Rival Product's Penetration October 25, 2022 Via Benzinga Albemarle To Rally Around 8%? Here Are 5 Other Price Target Changes For Thursday October 13, 2022 Berenberg raised Albemarle Corporation (NYSE: ALB) price target from $260 to $270. Berenberg analyst Andres Castanos Mollor downgraded the stock from Buy to Hold. Albemarle shares fell 7.9% to close at... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.